
Avoid co-administration of ixazomib with strong CYP3A inducers (e.g., rifampicin, phenytoin sodium, carbamazepine, and St. John's wort).
from FDA,2024.07
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unresectable or metastati···【more】
Recommended:272026-08-01
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cancer cells.Which drugs ···【more】
Recommended:322026-08-01
Ixazomib Citrate is approved for use in combination with lenalidomide and dexamethasone for the trea···【more】
Recommended:292026-08-01
Trametinib (Mekinist) is a targeted therapy indicated for the treatment of unresectable or metastatic melanoma harboring BRAF V600E or V600K mutations. As a prescription-only medic···【more】
Article source:Lucius LaosRelease date:2026-01-08Recommended:27
Ixazomib is a proteasome inhibitor, and its mechanism of action helps kill cancer cells.Which drugs interact with Ixazomib?Concurrent use of this product with any of the following ···【more】
Article source:Lucius LaosRelease date:2026-01-08Recommended:32
Ixazomib Citrate is approved for use in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior lin···【more】
Article source:Lucius LaosRelease date:2026-01-08Recommended:29

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: